Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$5.40 B

According to Lundbeck 's latest financial reports the company has NZ$5.40 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lundbeck - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$5.16 B9.54%
2022-12-31$NZ$4.71 B15.98%
2021-12-31$NZ$4.06 B4.17%
2020-12-31$NZ$3.90 B4.58%
2019-12-31$NZ$3.73 B14.64%
2018-12-31$NZ$3.25 B17.67%
2017-12-31$NZ$2.76 B39.54%
2016-12-31$NZ$1.98 B5.22%
2015-12-31$NZ$1.88 B-33.13%
2014-12-31$NZ$2.81 B-7.33%
2013-12-31$NZ$3.03 B6.46%
2012-12-31$NZ$2.85 B0.09%
2011-12-31$NZ$2.85 B10.4%
2010-12-31$NZ$2.58 B9.83%
2009-12-31$NZ$2.35 B-3.8%
2008-12-31$NZ$2.44 B34.35%
2007-12-31$NZ$1.81 B6.88%
2006-12-31$NZ$1.70 B-1.89%
2005-12-31$NZ$1.73 B-13.22%
2004-12-31$NZ$1.99 B